Aberrant histone acetylation and methylation levels in woman with endometriosis

Archives of Gynecology and Obstetrics

Volumn 287, Issue 3, 2013, Pages 487-494

  Xiaomeng, Xia ^a   Ming, Zhao ^a   Jiezhi, Ma ^a   Xiaoling, Fang ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Acetylation; Endometriosis; Histone; Methylation; Post translational modification

Indexed keywords

BETA ACTIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; E1A ASSOCIATED P300 PROTEIN; HISTONE ACETYLTRANSFERASE PCAF; HISTONE DEACETYLASE 1; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE 4; HISTONE DEACETYLASE 5; HISTONE DEACETYLASE 7; HISTONE H3; HISTONE H4; MESSENGER RNA; SIRTUIN 1;

ADULT; ARTICLE; BETA ACTIN GENE; CHROMATIN; CLINICAL ARTICLE; CONTROLLED STUDY; CREBBP GENE; ENDOMETRIOSIS; EPIGENETICS; FEMALE; G9A GENE; GENE; GENE EXPRESSION; HISTONE DEACETYLASE 1 GENE; HISTONE DEACETYLASE 2 GENE; HISTONE DEACETYLASE 4 GENE; HISTONE DEACETYLASE 5 GENE; HISTONE DEACETYLASE 7 GENE; HISTONE HYPOACETYLATION; HISTONE HYPOMETHYLATION; HISTONE MODIFICATION; HUMAN; HUMAN TISSUE; MOLECULAR PATHOLOGY; P300 GENE; PCAF GENE; REAL TIME POLYMERASE CHAIN REACTION; SIRT1 GENE; SUV39H1 GENE; SUV39H2 GENE;

ACETYLATION; ADULT; CASE-CONTROL STUDIES; ENDOMETRIOSIS; ENDOMETRIUM; EPIGENESIS, GENETIC; FEMALE; HISTONE ACETYLTRANSFERASES; HISTONE DEACETYLASES; HISTONE-LYSINE N-METHYLTRANSFERASE; HISTONES; HUMANS; METHYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; RNA, MESSENGER; YOUNG ADULT;

EID: 84878374273     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-012-2591-0     Document Type: Article

References (45)

1. Giudice LC, Kao LC (2004) Endometriosis. Lancet 364:1789-1799
2. Eskenazi B, Warner ML (1997) Epidemiology of endometriosis. Obstet Gynecol Clin North Am 24:235-258
3. Wheeler JM (1989) Epidemiology of endometriosis-associated infertility. J Reprod Med 34:41-46
4. Gurates B, Bulun SE (2003) Endometriosis: the ultimate hormonal disease. Semin Reprod Med 21:125-134
5. Bulun SE, Yang S, Fang Z, Gurates B, Tamura M, Sebastian S (2002) Estrogen production and metabolism in endometriosis. Ann N Y Acad Sci 955:75-85 (discussion 86-88, 396-406)
6. Paul DW, Braun DP (2004) Immunology of endometriosis. Best Pract Res Clin Obstet Gynaecol 18:245-263
7. Ulukus M, Arici A (2005) Immunology of endometriosis. Minerva Ginecol 57:237-248
8. Barlow DH, Kennedy S (2005) Endometriosis: new genetic approaches and therapy. Annu Rev Med 56:345-356
9. Simpson JL, Bischoff FZ, Kamat A, Buster JE, Carson SA (2003) Genetics of endometriosis. Obstet Gynecol Clin North Am 30:21-40
10. Rier SE (2002) The potential role of exposure to environmental toxicants in the pathophysiology of endometriosis. Ann N Y Acad Sci 955:201-212 (discussion 230-2, 396-406)
11. Guo SW (2009) Epigenetics of endometriosis. Mol Hum Reprod 15:587-607
12. Rodenhiser D, Mann M (2006) Epigenetics and human disease: translating basic biology into clinical applications. CMAJ 174:341-348
13. Vialou V (2010) Histone acetylation, gene regulation and depression. Med Sci (Paris) 26:465-467
14. Schubeler D, Lorincz MC, Cimbora DM, Telling A, Feng YQ, Bouhassira EE, Groudine M (2000) Genomic targeting of methylated DNA: influence of methylation on transcription, replication, chromatin structure, and histone acetylation. Mol Cell Biol 20:9103-9112
15. Peterson CL, Laniel MA (2004) Histones and histone modifications. Curr Biol 14:R546-R551
16. Costa FF (2008) Non-coding RNAs, epigenetics and complexity. Gene 410:9-17
17. Verdone L, Agricola E, Caserta M, Di Mauro E (2006) Histone acetylation in gene regulation. Brief Funct Genomic Proteomic 5:209-221
18. Wu Y, Strawn E, Basir Z, Halverson G, Guo SW (2007) Aberrant expression of deoxyribonucleic acid methyltransferases DNMT1, DNMT3A, and DNMT3B in women with endometriosis. Fertil Steril 87:24-32
19. Wu Y, Halverson G, Basir Z, Strawn E, Yan P, Guo SW (2005) Aberrant methylation at HOXA10 may be responsible for its aberrant expression in the endometrium of patients with endometriosis. Am J Obstet Gynecol 193:371-380
20. Yang J, Fang X (2012) Expression of DNMT1, DNMT3a, and DNMT3b in eutopic endometrium. Zhong Nan Da Xue Xue Bao Yi Xue Ban 37:94-99
21. Li JX, Liu HL (2004) The relationship of DNA methylation and histone methylation. Yi Chuan 26:267-270
22. Tariq M, Paszkowski J (2004) DNA and histone methylation in plants. Trends Genet 20:244-251
23. Ebert A, Lein S, Schotta G, Reuter G (2006) Histone modification and the control of heterochromatic gene silencing in Drosophila. Chromosom Res 14:377-392
24. Bird A (2001) Molecular biology. Methylation talk between histones and DNA. Science 294:2113-2115
25. Ruthenburg AJ, Allis CD, Wysocka J (2007) Methylation of lysine 4 on histone H3: intricacy of writing and reading a single epigenetic mark. Mol Cell 25:15-30
26. Shi X, Hong T, Walter KL, Ewalt M, Michishita E, Hung T, Carney D, Pena P, Lan F, Kaadige MR, Lacoste N, Cayrou C, Davrazou F, Saha A, Cairns BR, Ayer DE, Kutateladze TG, Shi Y, Cote J, Chua KF, Gozani O (2006) ING2 PHD domain links histone H3 lysine 4 methylation to active gene repression. Nature 442:96-99
27. Rice JC, Briggs SD, Ueberheide B, Barber CM, Shabanowitz J, Hunt DF, Shinkai Y, Allis CD (2003) Histone methyltransferases direct different degrees of methylation to define distinct chromatin domains. Mol Cell 12:1591-1598
28. Eskeland R, Eberharter A, Imhof A (2007) HP1 binding to chromatin methylated at H3K9 is enhanced by auxiliary factors. Mol Cell Biol 27:453-465
29. Smallwood A, Esteve PO, Pradhan S, Carey M (2007) Functional cooperation between HP1 and DNMT1 mediates gene silencing. Genes Dev 21:1169-1178
30. Lehnertz B, Ueda Y, Derijck AA, Braunschweig U, Perez-Burgos L, Kubicek S, Chen T, Li E, Jenuwein T, Peters AH (2003) Suv39h-mediated histone H3 lysine 9 methylation directs DNA methylation to major satellite repeats at pericentric heterochromatin. Curr Biol 13:1192-1200
31. Santos-Rosa H, Caldas C (2005) Chromatin modifier enzymes, the histone code and cancer. Eur J Cancer 41:2381-2402
32. Vigano P, Somigliana E, Chiodo I, Abbiati A, Vercellini P (2006) Molecular mechanisms and biological plausibility underlying the malignant transformation of endometriosis: a critical analysis. Hum Reprod Updat 12:77-89
33. Vigushin DM, Coombes RC (2002) Histone deacetylase inhibitors in cancer treatment. Anticancer Drugs 13:1-13
34. Mahlknecht U, Hoelzer D (2000) Histone acetylation modifiers in the pathogenesis of malignant disease. Mol Med 6:623-644
35. Kawano Y, Nasu K, Li H, Tsuno A, Abe W, Takai N, Narahara H (2011) Application of the histone deacetylase inhibitors for the treatment of endometriosis: histone modifications as pathogenesis and novel therapeutic target. Hum Reprod 26:2486-2498
36. Park JH, Jung Y, Kim TY, Kim SG, Jong HS, Lee JW, Kim DK, Lee JS, Kim NK, Kim TY, Bang YJ (2004) Class I histone deacetylase-selective novel synthetic inhibitors potently inhibit human tumor proliferation. Clin Cancer Res 10:5271-5281
37. Minucci S, Pelicci PG (2006) Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer. Nat Rev Cancer 6:38-51
38. Colon-Diaz M, Baez-Vega P, Garcia M, Ruiz A, Monteiro JB, Fourquet J, Bayona M, Alvarez-Garriga C, Achille A, Seto E, Flores I (2012) HDAC1 and HDAC2 are differentially expressed in endometriosis. Reprod Sci 19:483-492
39. Imesch P, Samartzis EP, Schneider M, Fink D, Fedier A (2011) Inhibition of transcription, expression, and secretion of the vascular epithelial growth factor in human epithelial endometriotic cells by romidepsin. Fertil Steril 95:1579-1583
40. Imesch P, Fink D, Fedier A (2010) Romidepsin reduces histone deacetylase activity, induces acetylation of histones, inhibits proliferation, and activates apoptosis in immortalized epithelial endometriotic cells. Fertil Steril 94:2838-2842
41. + dependent histone deacetylases (sirtuins) in ageing. Curr Drug Targ 7:1553-1560
42. Chua KF, Mostoslavsky R, Lombard DB, Pang WW, Saito S, Franco S, Kaushal D, Cheng HL, Fischer MR, Stokes N, Murphy MM, Appella E, Alt FW (2005) Mammalian SIRT1 limits replicative life span in response to chronic genotoxic stress. Cell Metab 2:67-76
43. Luo J, Nikolaev AY, Imai S, Chen D, Su F, Shiloh A, Guarente L, Gu W (2001) Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell 107:137-148
44. Yeung F, Hoberg JE, Ramsey CS, Keller MD, Jones DR, Frye RA, Mayo MW (2004) Modulation of NF-kappa B-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J 23:2369-2380
45. Defrere S, Gonzalez-Ramos R, Lousse JC, Colette S, Donnez O, Donnez J, Van Langendonckt A (2011) Insights into iron and nuclear factor-kappa B (NF-kappa B) involvement in chronic inflammatory processes in peritoneal endometriosis. Histol Histopathol 26:1083-1092